Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel
strain that causes acute respiratory illnesses known as coronavirus disease 2019 (COVID …

Innate immunity is the front-line defense against infectious microorganisms, including
viruses and bacteria. Type I interferons are pleiotropic cytokines that perform antiviral …

Recent data suggest a suboptimal antibody response to COVID-19 vaccination in patients
with hematological malignancies. Neutralizing antibodies (NAbs) against SARS-CoV-2 were …

COVID-19 patients typically present with lower airway disease, although involvement of
other organ systems is usually the rule. Hematological manifestations such as …

Patients with multiple myeloma (MM) are at an increased risk for infection because of their
immunocompromised state, old age, and comorbidities. 1 Coronavirus disease 2019 …

Elucidating the characteristics of human immune response against SARS-CoV-2 is of high
priority and relevant for determining vaccine strategies. We report the results of a follow-up …

Immunocompromised patients with hematologic malignancies are more susceptible to
COVID-19 and at higher risk of severe complications and worse outcomes compared with …

The SARS-CoV-2 virus has caused a worldwide COVID-19 pandemic. In less than a year
and a half, more than 200 million people have been infected and more than four million …

The aim of this study was to investigate the kinetics of neutralizing antibodies (NAbs) and
anti-SARS-CoV-2 anti-S-RBD IgGs up to three months after the second vaccination dose …

In patients with coronavirus disease 2019 (COVID-19), men are more severely affected than
women. Multiple studies suggest that androgens might play a role in this difference in …